Abstract
Background Vaccination is the most effective means to prevent the spread of infectious diseases. Despite the proven benefits of vaccination, complacency, constraints, and lacking confidence keep many people away from getting vaccinated. This study investigates how written reminders with varying information contents to address vaccine hesitancy affect influenza vaccination coverage in two large and representative samples of older adults.
Methods We implemented a large-scale cluster-randomized controlled trial in Finland. The study included the entire elderly population (≥ 65 years of age) in two culturally and geographically distinct regions with a historically low (31·8%, N = 7398) and high (57·7%, N = 40727) influenza vaccination coverage. Participants were randomized before the influenza season 2018 – 2019 into three treatments: (i) no information letter, (ii) a standard information letter, reminding recipients about the individual benefits of vaccination, and (iii) a tailored information letter, reminding recipients about the additional social benefits of vaccination due to herd effect. The impact of varying information treatments on influenza vaccination coverage was measured using individual-level administrative health records.
Findings Our results showed that a low-cost and scalable information intervention relying on individually mailed letters increased influenza vaccination coverage by 6·4 percentage points (95% CI: 4·1 to 8·8). The effect was particularly large among individuals with no prior influenza vaccination (8·8 pp, 95% CI: 6·5 to 11·1). Moreover, we observed a substantial positive effect (5·3 pp, 95% CI: 2·8 to 7·8) among the most consistently non-vaccinated individuals who had not received any type of vaccine during the previous nine years. There were no cross-vaccine spillovers to other age-appropriate vaccines. Our results further suggest that there was no difference in influenza vaccination coverage between the standard letter and the tailored letter that informed individuals about the social benefits of vaccination (0·2 pp, 95% CI: - 0·1 to 1·3).
Interpretation Sending information letters is an effective and easily scalable low-cost intervention strategy to increase vaccine uptake in an elderly population. Communicating the social benefits of vaccination in addition to individual benefits does not enhance influenza vaccine uptake. The effectiveness of behavioral interventions aiming to improve vaccination coverage crucially depends on the prior vaccination history of the target population. These findings have meaningful implications for public health authorities who implement vaccine communication strategies to enhance vaccine uptake and aim to curb the spread of infectious diseases.
Funding The authors received no external funding for this work. The costs of preparing (e.g. printing the letters and acquiring envelopes) and mailing the letters (postal fees) were paid by the Finnish Institute for Health and Welfare and the City of Espoo.
Competing Interest Statement
The authors have declared no competing interest.
Clinical Trial
As this study spans multiple disciplines, we pre-registered the experimental design and submitted the pre-analysis plan to multiple registries: the U.S National Library of Medicine Registry for clinical trials (clinicaltrial.gov, trial number: 240317), the American Economic Association Registry for randomized controlled trials (trial number: AEARCTR-0003520), and aspredicted.org (trial number: #15682).
Funding Statement
Funding The authors received no external funding for this work. The costs of preparing (e.g. printing the letters and acquiring envelopes) and mailing the letters (postal fees) were paid by the Finnish Institute for Health and Welfare and the City of Espoo.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
The study protocol was approved by the Finnish Institute for Health and Welfare Institutional Review Board (Decision Number: THL/1444/6.02.01/2018).
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
De-identified individual-level data will be shared using the Open Science Framework data repository. Data sharing will commence immediately following publication. Statistical code to organize the data and replicate the statistical analysis is made available using the Open Science Framework data repository.
